QT
CTKB icon

Quantbot Technologies’s Cytek Biosciences CTKB Stock Holding History

Quantbot Technologies’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,533
Closed -$195K – 1780
2025
Q4 		$195K Buy
38,533
+4,626
+14% +$21.5K 0.01% 1245
2025
Q3 		$118K Buy
33,907
+9,176
+37% +$34.4K ﹤0.01% 1416
2025
Q2 		$84.1K Buy
+24,731
New +$82.4K ﹤0.01% 1434
2023
Q4 		– Sell
-46,452
Closed -$256K – 1633
2023
Q3 		$256K Buy
+46,452
New +$373K 0.02% 830
2023
Q1 		– Sell
-12,882
Closed -$132K – 1640
2022
Q4 		$132K Buy
+12,882
New +$173K 0.01% 1044

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Quantbot Technologies's CTKB Position: Q1 2026 in Review

Quantbot Technologies sold out of Cytek Biosciences (CTKB) in Q1 2026, closing a stake of 38,533 shares — an estimated $195K sold.

Quantbot Technologies first reported a position in CTKB in Q4 2022 and held it in 5 quarters. The position peaked at $256K in Q3 2023. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • Quantbot Technologies reported no remaining Cytek Biosciences position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 38,533 Cytek Biosciences shares in Q1 2026, an estimated $195K.
  • Quantbot Technologies first reported a position in Cytek Biosciences in Q4 2022 and held it in 5 quarters.
  • Quantbot Technologies's Cytek Biosciences position peaked at $256K in Q3 2023.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.